Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013

Social Media in the Pharmaceutical Industry

23 Jan 2013 - 24 Jan 2013 - London, UK

Bookmark and Share

Connectivity, Engagement and Implementation

Sponsored by: greater than one

Book by 28th September and receive a £300 discount

Visit to claim your discount!

SMi Group is proud to present the 5th conference in their highly successful series of Social Media in the Pharmaceutical Industry this January that will allow companies to focus on how to improve their existing social media strategies, how to innovate into the new and emerging techniques and technologies and enhancing their company’s engagement potential. We are excited to also feature talks from key companies in the industry, including Google, Pfizer, UCB Pharma and Bayer, and will focus on case studies from the industry, techniques for social media use and implementation of social media mechanisms. 

Key reasons to attend include:

Speak with the key opinion leaders of the industry about the future of social media, digital pharma, e-marketing and regulations

Hear about the case studies in the industry: how the affected those involved, how they were successful and the reasons that they were unsuccessful

Learn about crisis management, adaptations and risk management in unsuccessful campaigns, and apply them to your own company’s

Discuss the latest technologies in social media with companies that create them, and debate their benefits and difficulties with those companies that utilise them

Put forward problems and difficulties of your own, and discuss potential solutions and action plans for the future

Expert Key speakers include:

Beat Buehlmann, Industry Leader Healthcare UK, Google Inc

Trish Nettleship, Director, Social Media & Influence, UCB Pharma

 • Rahul Agrawal, Global Director, Clinical Development and Strategic 

Marketing, Bayer Healthcare

Andrew Widger, Director, Media Relations EMEA Pfizer Inc

Josep Picas, President, European Association of Healthcare IT Managers

Contact Fateja Begum on tel +44 0 207 827 6184 or email 

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos